Loading clinical trials...
Loading clinical trials...
Randomized Prospective Phase III Clinical Trial Comparing HLA 10/10 Matched Unrelated Donor and Haploidentical Allogenic Hematopoietic Stem Cell Transplantation After Myeloablative Conditioning Regimen
Conditions
Interventions
Haplo donor stem cell transplantation
HLA 10/10 MUD stem cell transplantation
Start Date
August 1, 2018
Primary Completion Date
June 1, 2019
Completion Date
June 1, 2023
Last Updated
August 31, 2018
NCT06285890
NCT05376111
NCT06220162
NCT04065399
NCT04628026
NCT06994676
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions